Can you provide information on whether Alexion Pharm Inc beat earnings estimates in the last quarter?
Alexion Pharm Inc (ALXN) beat EPS estimates and missed revenue estimates in the most recent quarter.
NASDAQ:ALXN
Past quarterly earnings results for Alexion Pharm Inc (ALXN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in ): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2021 | 3.52 | 3.23 | 9.09% | 9.32% | 1.607B | - | 16.20% | |
| Q4 2020 | 2.96 | 2.61 | 13.46% | - | 1.541B | - | - | |
| Q3 2020 | 3.24 | 2.65 | 22.17% | - | 1.448B | - | - | |
| Q2 2020 | 3.11 | 2.64 | 17.70% | - | 1.298B | - | - | |
| Q1 2020 | 3.22 | 2.77 | 16.46% | - | 1.383B | - | - |
Notes
Alexion Pharm Inc (ALXN) beat EPS estimates and missed revenue estimates in the most recent quarter.